Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Recent advances in in vitro models simulating the female genital tract toward more effective intravaginal therapeutic delivery
Publication

Publications

Recent advances in in vitro models simulating the female genital tract toward more effective intravaginal therapeutic delivery

Title
Recent advances in in vitro models simulating the female genital tract toward more effective intravaginal therapeutic delivery
Type
Another Publication in an International Scientific Journal
Year
2024
Authors
Silva, B
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Gomes, AC
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Pages: 1-21
ISSN: 1742-5247
Publisher: Taylor & Francis
Indexing
Publicação em ISI Web of Knowledge ISI Web of Knowledge - 0 Citations
Publicação em Scopus Scopus - 0 Citations
Other information
Authenticus ID: P-011-MTV
Abstract (EN): Introduction: Intravaginal drug delivery has emerged as a promising avenue for treating a spectrum of systemic and local female genital tract (FGT) conditions, using biomaterials as carriers or scaffolds for targeted and efficient administration. Much effort has been made to understand the natural barriers of this route and improve the delivery system to achieve an efficient therapeutic response. Areas covered: In this review, we conducted a comprehensive literature search using multiple databases (PubMed Scopus Web of Science Google Scholar), to discuss the potential of intravaginal therapeutic delivery, as well as the obstacles unique to this route. The in vitro cell models of the FGT and how they can be applied to probing intravaginal drug delivery are then analyzed. We further explore the limitations of the existing models and the possibilities to make them more promising for delivery studies or biomaterial validation. Complementary information is provided by in vitro acellular techniques that may shed light on mucus-drug interaction. Expert opinion: Advances in 3D models and cell cultures have enhanced our understanding of the FGT, but they still fail to replicate all variables. Future research should aim to use complementary methods, ensure stability, and develop consistent protocols to improve therapy evaluation and create better predictive in vitro models for women's health. [GRAPHICS]
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 21
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the delivery of bioactives sourced from plants: part II - applications and preclinical advancements (2024)
Another Publication in an International Scientific Journal
Fathi, F; Machado, TOX; Kodel, H; Portugal, I; Ferreira, IO; Zielinska, A; Beatriz B P P Oliveira; Souto, EB
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the delivery of bioactives sourced from plants: part I - composition and production methods (2024)
Another Publication in an International Scientific Journal
Fathi, F; Machado, TOX; Kodel, HDC; Portugal, I; Ferreira, IO; Zielinska, A; Beatriz B P P Oliveira; Souto, EB
Nanostructured lipid carrier-based hydrogel formulations for drug delivery: A comprehensive review (2009)
Another Publication in an International Scientific Journal
Doktorovova, S; Souto, EB
Forward (2013)
Another Publication in an International Scientific Journal
Souto, EB
Foreword (2013)
Another Publication in an International Scientific Journal
Souto, EB

See all (14)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-09 at 22:06:48 | Privacy Policy | Personal Data Protection Policy | Whistleblowing